Quarterly report · Q3
2112.TEDINET S100Q2HZ
Period2022-04-01 → 2022-12-31
Filed2023-02-03
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥21.2bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥25.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥19.3bn | 2021-04-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | ¥549m | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥712m | 2021-04-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥560m | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥906m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥683m | 2021-04-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥560m | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥683m | 2021-04-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥349m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥609m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥427m | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥349m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥427m | 2021-04-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥25.9bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥26.1bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥26.2bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥15.0bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥15.7bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥10.9bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥10.4bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥10.1bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.6bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.5bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥12.83 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.73 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.43 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥15.74 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.13 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 42.0% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.7% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.5% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2022-04-01 → 2022-12-31 | ¥100m |
| Otherother segments | revenue external | 2022-04-01 → 2022-12-31 | ¥88m |
| Otherother segments | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥12m |
| Otherother segments | segment profit | 2022-04-01 → 2022-12-31 | ¥46m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥69m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥69m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥841m |
| jpcrp040300-q3r_E00361-000Biotechnologyreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥1.4bn |
| jpcrp040300-q3r_E00361-000Biotechnologyreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥1.4bn |
| jpcrp040300-q3r_E00361-000Biotechnologyreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥35m |
| jpcrp040300-q3r_E00361-000Biotechnologyreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥354m |
| jpcrp040300-q3r_E00361-000Sugarreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥19.8bn |
| jpcrp040300-q3r_E00361-000Sugarreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥19.7bn |
| jpcrp040300-q3r_E00361-000Sugarreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥21m |
| jpcrp040300-q3r_E00361-000Sugarreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥990m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥21.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥21.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥69m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥1.4bn |
| Otherother segments | revenue | 2021-04-01 → 2021-12-31 | ¥99m |
| Otherother segments | revenue external | 2021-04-01 → 2021-12-31 | ¥87m |
| Otherother segments | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥12m |
| Otherother segments | segment profit | 2021-04-01 → 2021-12-31 | ¥45m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-12-31 | −¥63m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-12-31 | −¥63m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-12-31 | −¥868m |
| jpcrp040300-q3r_E00361-000Biotechnologyreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥1.4bn |
| jpcrp040300-q3r_E00361-000Biotechnologyreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥1.4bn |
| jpcrp040300-q3r_E00361-000Biotechnologyreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥30m |
| jpcrp040300-q3r_E00361-000Biotechnologyreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥386m |
| jpcrp040300-q3r_E00361-000Sugarreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥17.8bn |
| jpcrp040300-q3r_E00361-000Sugarreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥17.8bn |
| jpcrp040300-q3r_E00361-000Sugarreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥21m |
| jpcrp040300-q3r_E00361-000Sugarreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-12-31 | ¥19.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-12-31 | ¥19.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥63m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-12-31 | ¥1.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 355
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |